Payne Fletcher 4
4 · Aptose Biosciences Inc. · Filed Jan 23, 2023
Insider Transaction Report
Form 4
Payne Fletcher
SR VP & Chief Fin. Officer
Transactions
- Award
Common Shares
2023-01-19+100,000→ 100,000 total - Award
Employee Stock Option (Right to Buy)
2023-01-19+200,000→ 200,000 totalExercise: $0.66Exp: 2033-01-19→ Common Shares (200,000 underlying)
Holdings
- 10,000(indirect: By Trust)
Common Shares
Footnotes (1)
- [F1]Fifty percent (50%) of the options vest on January 19, 2024; the remaining fifty percent (50%) vest as follows: One-third (1/3) on January 19, 2025; one-third (1/3) on January 19, 2026; and one-third (1/3) on January 19, 2027.